GFOD2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the protein encoded by the GFOD2 gene. GFOD2 (Glucose-Fructose Oxidoreductase Domain Containing 2) is a lesser-studied protein believed to play roles in various cellular processes, potentially linked to glucose and fructose metabolism due to its domain homology with oxidoreductases. Inhibitors of GFOD2 are often small molecules that interact directly with the active site or allosteric sites of the protein to modulate its enzymatic activity. These inhibitors are structurally diverse, with different classes displaying various scaffold chemistries that allow for specific binding and selectivity toward GFOD2. The design of GFOD2 inhibitors relies on understanding the protein's structure, active site, and mechanisms of action to identify key molecular interactions that can be exploited for inhibition.
The discovery and optimization of GFOD2 inhibitors involve an iterative process of chemical modification to improve their binding affinity, selectivity, and stability. Structure-activity relationship (SAR) studies are crucial for elucidating how changes in the chemical structure affect the inhibition potency and specificity for GFOD2. Since the precise biological role of GFOD2 is not yet fully elucidated, the development of these inhibitors often includes a range of biochemical and biophysical assays to confirm target engagement and validate their ability to modulate the protein's function. Moreover, the development of such inhibitors requires balancing physicochemical properties, such as solubility and permeability, to ensure they are effective in interacting with the target protein within a cellular environment. By exploring diverse chemical spaces and structural motifs, GFOD2 inhibitors serve as valuable molecular tools for probing the function of GFOD2 in cellular processes, contributing to the broader understanding of this protein's role in biological pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that acts as a tyrosine kinase inhibitor, possibly impacting GFOD2 activity by altering phosphorylation states. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can disrupt multiple signaling pathways, possibly affecting GFOD2's regulatory mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphatidylinositol 3-kinase inhibitor, potentially altering signaling cascades that regulate GFOD2 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can disrupt downstream signaling, potentially influencing GFOD2 function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, potentially altering signaling pathways that intersect with GFOD2's regulatory scope. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, which can affect MAPK/ERK pathways and potentially modulate GFOD2 activity indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which may influence signaling pathways involving GFOD2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting stress-activated pathways related to GFOD2's regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor that can interfere with ERK signaling, possibly affecting GFOD2's activity. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
An inhibitor of JAK2 kinase, potentially disrupting signaling that could modulate GFOD2. | ||||||